Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Goodwill (2017 - 2025)

Organogenesis Holdings has reported Goodwill over the past 9 years, most recently at $28.8 million for Q4 2025.

  • Quarterly results put Goodwill at $28.8 million for Q4 2025, changed 0.0% from a year ago — trailing twelve months through Dec 2025 was $28.8 million (changed 0.0% YoY), and the annual figure for FY2025 was $28.8 million, changed 0.0%.
  • Goodwill for Q4 2025 was $28.8 million at Organogenesis Holdings, roughly flat from $28.8 million in the prior quarter.
  • Over the last five years, Goodwill for ORGO hit a ceiling of $28.8 million in Q1 2021 and a floor of $28.8 million in Q1 2021.
  • Median Goodwill over the past 5 years was $28.8 million (2021), compared with a mean of $28.8 million.
  • Peak annual rise in Goodwill hit 12.66% in 2021, while the deepest fall reached 0.5% in 2021.
  • Organogenesis Holdings' Goodwill stood at $28.8 million in 2021, then changed by 0.0% to $28.8 million in 2022, then changed by 0.0% to $28.8 million in 2023, then changed by 0.0% to $28.8 million in 2024, then changed by 0.0% to $28.8 million in 2025.
  • The last three reported values for Goodwill were $28.8 million (Q4 2025), $28.8 million (Q3 2025), and $28.8 million (Q2 2025) per Business Quant data.